IPAC2017 - List of Keywords (isotope-production)

Paper	Title	Other Keywords	Page
WEOBB1	Recirculated Electron Beam Photo-Converter for Rare Isotope Production	target, electron, photon, TRIUMF	2526
	A. Laxdal, R.A. Baartman, I.V. Bylinskii, S. Ganesh, A. Gottberg, F.W. Jones, P. Kunz, L.A. Lopera, T. Planche, A. Sen TRIUMF, Vancouver, Canada
	The TRIUMF 50 MeV electron linac has the potential to drive cw beams of up to 0.5 MW to the ARIEL photo-fission facility for rare isotope science. Due to the cooling requirements, the use of a thick Bremsstrahlung target for electron to photon conversion is a difficult technical challenge in this intensity regime. Here we present a different concept in which electrons are injected into a small storage ring to make multiple passes through a thin internal photo-conversion target, eventually depositing their remaining energy in a cooled central core absorber. We discuss the design requirements and propose a set of design parameters for the Fixed Field Alternating Gradient (FFAG) ring. Using particle simulation models, we estimate various beam properties, as well as the MPS for the electron loss.
	Slides WEOBB1 [4.650 MB]
DOI •	reference for this paper ※ https://doi.org/10.18429/JACoW-IPAC2017-WEOBB1
Export •	reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)

THPVA130	Modelling PET Radionuclides Production in Tissue and External Targets Using Geant4	proton, target, cyclotron, TRIUMF	4757
	A. Amin, R.J. Barlow IIAA, Huddersfield, United Kingdom C.M. Hoehr, C. Lindsay TRIUMF, Vancouver, Canada A. Infantino CERN, Geneva, Switzerland
	The Proton Therapy Facility in TRIUMF provides 74 MeV protons extracted from a 500 MeV H⁻ cyclotron for ocular melanoma treatments. During treatment, positron emitting radionuclides such as C-11, O-15 and N-13 are produced in patient tissue. Using PET scanners, the isotopic activity distribution can be measured for in-vivo range verification. A second cyclotron, the TR13, provides 13 MeV protons onto liquid targets for the production of PET radionuclides such as F-18, N-13 or Ga-68, for medical applications. The aim of this work was to validate Geant4 against FLUKA and experimental measurements for production of the above-mentioned isotopes using the two cyclotrons. The results show variable degrees of agreement. For proton therapy, the proton-range agreement was within 2 mm for C-11 activity, whereas N-13 disagreed. For liquid targets at the TR13 the average absolute deviation ratio between FLUKA and experiment was 1.9±2.8, whereas the average absolute deviation ratio between Geant4 and experiment was 0.6±0.4. This is due to the uncertainties present in experimentally determined reaction cross sections.
DOI •	reference for this paper ※ https://doi.org/10.18429/JACoW-IPAC2017-THPVA130
Export •	reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)

FRXBA1	Compact and Efficient Accelerators for Radioisotope Production	cyclotron, target, electron, linac	4824
	C. Oliver CIEMAT, Madrid, Spain
	The production in an efficient way of radioisotopes for medical use is crucial. With the closing in the next ten years of nuclear reactors the problem of the production of some of them is being critical. New approaches of producing these radioisotopes via accelerators are being developed. In the other hand a big effort is being made for making the accelerators for the production of radioisotopes more compact, efficient and with an optimized cost. This paper describes the recent advances in this kind of accelerator techniques.
	Slides FRXBA1 [2.797 MB]
DOI •	reference for this paper ※ https://doi.org/10.18429/JACoW-IPAC2017-FRXBA1
Export •	reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)

Paper

Title

Other Keywords

Page

WEOBB1

Recirculated Electron Beam Photo-Converter for Rare Isotope Production

target, electron, photon, TRIUMF

2526

A. Laxdal, R.A. Baartman, I.V. Bylinskii, S. Ganesh, A. Gottberg, F.W. Jones, P. Kunz, L.A. Lopera, T. Planche, A. Sen
TRIUMF, Vancouver, Canada

The TRIUMF 50 MeV electron linac has the potential to drive cw beams of up to 0.5 MW to the ARIEL photo-fission facility for rare isotope science. Due to the cooling requirements, the use of a thick Bremsstrahlung target for electron to photon conversion is a difficult technical challenge in this intensity regime. Here we present a different concept in which electrons are injected into a small storage ring to make multiple passes through a thin internal photo-conversion target, eventually depositing their remaining energy in a cooled central core absorber. We discuss the design requirements and propose a set of design parameters for the Fixed Field Alternating Gradient (FFAG) ring. Using particle simulation models, we estimate various beam properties, as well as the MPS for the electron loss.

Slides WEOBB1 [4.650 MB]

DOI •

reference for this paper ※ https://doi.org/10.18429/JACoW-IPAC2017-WEOBB1

Export •

reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)

THPVA130

Modelling PET Radionuclides Production in Tissue and External Targets Using Geant4

proton, target, cyclotron, TRIUMF

4757

A. Amin, R.J. Barlow
IIAA, Huddersfield, United Kingdom
C.M. Hoehr, C. Lindsay
TRIUMF, Vancouver, Canada
A. Infantino
CERN, Geneva, Switzerland

The Proton Therapy Facility in TRIUMF provides 74 MeV protons extracted from a 500 MeV H⁻ cyclotron for ocular melanoma treatments. During treatment, positron emitting radionuclides such as C-11, O-15 and N-13 are produced in patient tissue. Using PET scanners, the isotopic activity distribution can be measured for in-vivo range verification. A second cyclotron, the TR13, provides 13 MeV protons onto liquid targets for the production of PET radionuclides such as F-18, N-13 or Ga-68, for medical applications. The aim of this work was to validate Geant4 against FLUKA and experimental measurements for production of the above-mentioned isotopes using the two cyclotrons. The results show variable degrees of agreement. For proton therapy, the proton-range agreement was within 2 mm for C-11 activity, whereas N-13 disagreed. For liquid targets at the TR13 the average absolute deviation ratio between FLUKA and experiment was 1.9±2.8, whereas the average absolute deviation ratio between Geant4 and experiment was 0.6±0.4. This is due to the uncertainties present in experimentally determined reaction cross sections.

DOI •

reference for this paper ※ https://doi.org/10.18429/JACoW-IPAC2017-THPVA130

Export •

reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)

FRXBA1

Compact and Efficient Accelerators for Radioisotope Production

cyclotron, target, electron, linac

4824

C. Oliver
CIEMAT, Madrid, Spain

The production in an efficient way of radioisotopes for medical use is crucial. With the closing in the next ten years of nuclear reactors the problem of the production of some of them is being critical. New approaches of producing these radioisotopes via accelerators are being developed. In the other hand a big effort is being made for making the accelerators for the production of radioisotopes more compact, efficient and with an optimized cost. This paper describes the recent advances in this kind of accelerator techniques.

Slides FRXBA1 [2.797 MB]

DOI •

reference for this paper ※ https://doi.org/10.18429/JACoW-IPAC2017-FRXBA1

Export •

reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)